COMMUNIQUÉS West-GlobeNewswire

Auxly Announces Strategic Agreement with Lonza for Liquid Filled Capsules and Fill and Seal Technology
19/06/2019
VANCOUVER, British Columbia, June 19, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly ") is pleased to announce that Auxly’s wholly owned subsidiary, Dosecann Inc. (“ Dosecann ”) has entered [...]
IntelGenx Announces Addition of Peterborough’s Kawartha Centre as Montelukast VersaFilm® Phase 2a Clinical Trial Site
19/06/2019
SAINT LAURENT, Quebec, June 19, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that, the Kawartha Centre has agreed to participate in [...]
Intra-Cellular Therapies to Present at JMP Securities Life Sciences Conference
19/06/2019
NEW YORK, June 19, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Immuron to Commence US Non-Deal Institutional Investor Roadshow
19/06/2019
MELBOURNE, Australia, June 19, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the [...]
Momenta Pharmaceuticals Announces Settlement Agreement with Amphastar Resolving Enoxaparin Sodium Injection Litigation
19/06/2019
CAMBRIDGE, Mass., June 19, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated [...]
HempAmericana Announces Final Production Machinery and Timing for Initial Commercial Shipments
19/06/2019
NEW YORK, June 19, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”), an emerging leader in the CBD products market, is excited to announce the purchase and [...]
eSolutions Acquires RCM Software Vendor Practice Insight
19/06/2019
The acquisition demonstrates eSolutions’ continued commitment to invest in core solutions that support its customers and grow its overall capabilities OVERLAND PARK, Kan., June 19, 2019 (GLOBE NEWSWIRE) -- eSolutions, a [...]
Samumed Doses First Subject in Phase 3 STRIDES-X-ray Trial of Lorecivivint for the Treatment of Knee Osteoarthritis
19/06/2019
The study will measure clinical and structural effects to assess the disease-modifying capabilities of lorecivivint SAN DIEGO, June 19, 2019 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it has dosed the first [...]
Biotricity Doubles Sales Force – Expands Device Fleet by 59%
19/06/2019
REDWOOD CITY, Calif., June 19, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY ), a medical diagnostic and consumer healthcare technology company, today announced that it has expanded its fleet of Bioflux devices [...]
Major Shareholder Announcement
19/06/2019
Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; June 19, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) announces under reference to Section 30 of the Danish Capital Markets Act that [...]
Network Health Expands Relationship with Inovalon
19/06/2019
Leading Health Plan Extends Engagement and Adds CDEaaS™ and NLPaaS™ to Enable Fully Automated Capture and Analysis of Structured and Unstructured Clinical Data at Large Scale BOWIE, Md., June 19, 2019 (GLOBE NEWSWIRE [...]
Akari Therapeutics’ Nomacopan Demonstrates Positive Early Safety and Efficacy in Phase I/II Clinical Study in Moderate-to-Severe Atopic Keraconjunctivitis (AKC)
19/06/2019
Part A of a safety and efficacy study successfully completed with nomacopan eye drops which were well tolerated with no serious adverse events. Improvement in mean composite clinical efficacy score of 35% by Day 14 and [...]
Melinta Therapeutics Announces U.S. FDA Acceptance of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia
19/06/2019
~ Application Seeks to Expand Label to Include an Indication and Phase III Data for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia (CABP) ~ ~ PDUFA Date Set for October 24, 2019 ~ MORRISTOWN [...]
Scholar Rock to Present at the 2019 BMO Prescriptions for Success Healthcare Conference
19/06/2019
CAMBRIDGE, Mass., June 19, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth [...]
ProMIS Neurosciences Appoints Renowned Parkinson’s Disease Expert Dr. C. Warren Olanow to Scientific Advisory Board
19/06/2019
Internationally recognized leader in neurodegenerative diseases to advise on programs selectively targeting the toxic oligomer TORONTO and CAMBRIDGE, Mass., June 19, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. ( [...]
CURE Pharmaceutical [OTCQB:CURR] and Canopy Growth to Produce CBD Oral Thin Films
19/06/2019
OXNARD, Calif. , June 19, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it is collaborating with Canopy Growth Corporation (TSX: WEED) ( [...]
Arch Biopartners Announces Start of Phase I Human Trial for Metablok
19/06/2019
TORONTO, June 19, 2019 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today it has initiated the Phase I human trial for Metablok (“LSALT peptide”), [...]
Myriad Genetics Receives Second Insurance Reimbursement Decision for its BRACAnalysis® Diagnostic System in Japan
19/06/2019
BRACAnalysis Is Now Indicated as a Companion Diagnostic for Lynparza® (olaparib) in Women with Ovarian Cancer SALT LAKE CITY, June 19, 2019 (GLOBE NEWSWIRE) -- Myriad Genetic Laboratories, Inc., a wholly-owned [...]
PLx Pharma on Track for VAZALORE Regulatory Pathway
19/06/2019
HOUSTON, June 19, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent- [...]

Pages